InChI=1S/C50H67N7O7/c1- 32(2) 27- 38- 47(62) 57- 26- 18- 25- 40(57) 48(63) 56(8) 41(28- 33(3) 4) 45(60) 54- 50(5,6) 49(64) 53- 39(30- 35- 21- 14- 10- 15- 22- 35) 46(61) 55(7) 42(31- 36- 23- 16- 11- 17- 24- 36) 44(59) 51- 37(43(58) 52- 38) 29- 34- 19- 12- 9- 13- 20- 34/h9- 17,19- 24,32- 33,37- 42H,18,25- 31H2,1- 8H3,(H,51,59) (H,52,58) (H,53,64) (H,54,60) /t37- ,38- ,39- ,40- ,41- ,42- /m0/s1 |
SQMTYAXLBXITMO-UJKKYYSESA-N |
[H] [C@@] 12CCCN1C(=O) [C@H] (CC(C) C) NC(=O) [C@H] (Cc1ccccc1) NC(=O) [C@H] (Cc1ccccc1) N(C) C(=O) [C@H] (Cc1ccccc1) NC(=O) C(C) (C) NC(=O) [C@H] (CC(C) C) N(C) C2=O |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
cyclo(2- methyl- D- alanyl- L- phenylalanyl- N- methyl- L- phenylalanyl- L- phenylalanyl- L- leucyl- L- prolyl- N- methyl- L- leucyl)
|
(3S,9S,12S,15S,18S,23aS)- 9,12,15- tribenzyl- 2,6,6,11- tetramethyl- 3,18- bis(2- methylpropyl)hexadecahydro- 1H- pyrrolo[1,2- a][1,4,7,10,13,16,19]heptaazacyclohenicosine- 1,4,7,10,13,16,19- heptone
|
ChEBI
|
9685899
|
Reaxys Registry Number
|
Reaxys
|
14604342
|
PubMed citation
|
Europe PMC
|
14604343
|
PubMed citation
|
Europe PMC
|
|